OPKO Health
OPK
NZ$2.21
Share price
-0.75%
Change (1 day)
8.82%
Change (1 year)
Categories
Revenue for OPKO Health (OPK)
Revenue in 2025 (TTM): NZ$1.16 Billion
According to OPKO Health
's latest financial reports the company's current revenue (TTM 
) is NZ$1.14 Billion. In 2024 the company made a revenue of NZ$1.26 Billion a decrease over the revenue in the year 2023 that were of NZ$1.36 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for OPKO Health from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | NZ$1.16 B | -8.19% |
| 2024 | NZ$1.26 B | -7.39% |
| 2023 | NZ$1.36 B | -13.67% |
| 2022 | NZ$1.58 B | -39.13% |
| 2021 | NZ$2.59 B | 30.61% |
| 2020 | NZ$1.98 B | 48.55% |
| 2019 | NZ$1.33 B | -9.29% |
| 2018 | NZ$1.47 B | 4.98% |
| 2017 | NZ$1.40 B | -20.26% |
| 2016 | NZ$1.76 B | 145.47% |
| 2015 | NZ$0.71 B | 517.77% |
| 2014 | NZ$0.11 B | -0.99% |
| 2013 | NZ$0.11 B | 105.41% |
| 2012 | NZ$57.18 M | 59.52% |
| 2011 | NZ$35.84 M | -20.89% |
| 2010 | NZ$45.31 M | 150.34% |
| 2009 | NZ$18.1 M | 11.27% |
| 2008 | NZ$16.26 M | |
| 2001 | NZ$3.21 M | 64.46% |
| 2000 | NZ$1.95 M | -23.01% |
| 1999 | NZ$2.53 M | 2.78% |
| 1998 | NZ$2.46 M | 377.16% |
| 1997 | NZ$0.51 M | 21.75% |
| 1996 | NZ$0.42 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | NZ$148.58 B | 12,857.64% | 🇺🇸 USA |
 Abbott Laboratories ABT | NZ$70.43 B | 6,042.08% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | NZ$23.42 B | 1,943.16% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | NZ$27.63 B | 2,310.04% | 🇮🇱 Israel |
 Alnylam Pharmaceuticals
ALNY | NZ$3.90 B | 240.60% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$79.23 B | 6,809.70% | 🇺🇸 USA |
 LabCorp LH | NZ$21.91 B | 1,811.41% | 🇺🇸 USA |
 Ardelyx ARDX | NZ$0.60 B | -47.53% | 🇺🇸 USA |